You are here

cancer

Exact Sciences showcases early cancer detection test data at AACR meeting

Clinical Trials Arena

Fri, 11/15/24 - 11:13 am

Pharma’s grip on cancer R&D is having unintended consequences

Pharma Voice

Wed, 11/13/24 - 10:52 am

Roche teams up with transcription factor trailblazer Flare in new $1.8B-plus cancer pact

Fierce Biotech

Tue, 11/12/24 - 10:57 am

Flare Therapeutics

small molecule drugs

Daiichi Sankyo partners Alteogen on subcutaneous Enhertu

Pharmaphorum

Fri, 11/8/24 - 11:37 am

Radiopharma CDMO Nucleus lays out plan to triple manufacturing capacity, add 100 jobs

Fierce Pharma

Mon, 10/21/24 - 11:44 pm

Nucleus RadioPharma

Pediatric cancer drug shortage: 5 things to know

Beckers Hospital Review

Fri, 10/18/24 - 10:16 am

Regeneron takes the long-haul approach to oncology, stumbles and all

Pharma Voice

Thu, 10/10/24 - 09:52 am

Boehringer unveils $607M deal to land Circle's preclinical cancer program

Fierce Biotech

Wed, 10/9/24 - 09:55 am

Boehringer Ingelheim

drug development

Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA

BioSpace

Wed, 09/25/24 - 12:08 pm

Inflation Reduction Act

Bristol Myers Squibb

Want better cancer treatments? Make biopharma more like Silicon Valley

BioPharma Dive

Wed, 09/25/24 - 11:53 am

Starton successfully delivers cancer drug using on-body injector

Clinical Trials Arena

Thu, 09/19/24 - 11:05 am

Starton Therapeutics

on-body injector

How a radiopharma up-and-comer builds momentum in a surging space

Pharma Voice

Tue, 09/17/24 - 09:49 am

Ratio Therapeutics

radiopharmaceuticals

FDA approves Roche’s Tecentriq Hybreza for cancer

Yahoo Finance

Fri, 09/13/24 - 09:33 am

Tecentriq Hybreza

Gene therapy startup emerges with green light for first-of-its-kind trial

BioPharma Dive

Thu, 09/12/24 - 11:33 am

adeno-associated viruses

Bicara Therapeutics aims for up to $828 mln valuation in U.S. IPO

Reuters

Fri, 09/6/24 - 10:55 am

Bicara Therapeutics

Novartis builds out radiopharma production with expansion, new factory

BioPharma Dive

Wed, 09/4/24 - 10:44 pm

radiopharmaceuticals

Bayer partners with NextRNA on lncRNA-targeted small molecules for cancer

First Word Pharma

Wed, 08/28/24 - 11:38 am

Illumina Gets FDA Approval for Cancer Biomarker Test

Marketwatch

Tue, 08/27/24 - 11:14 am

TruSight Oncology

Talus Bio tacks on $11M to target hard-to-reach transcription factors

Fierce Biotech

Tue, 08/20/24 - 11:39 am

Talus Bioscience

transcription factors

Adcendo licenses Multitude anti-TF ADC in $1bn+ deal

Pharmaphorum

Tue, 08/20/24 - 10:27 am

antibody-drug conjugates

Multitude Therapeutics

Pages